EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Evaluation of Drug-Related Problems in Non-Dialysis Chronic Kidney Disease at Northwest General Hospital Peshawar: A Cross-Sectional Study

Aizaz Ahmed, Fawad Ali, Farmanullah, Sajid Khan Sadozai, Sajid Hussain, Uzifa Shinwari, Abdul Saboor Pirzada, Muhammad Ikram, Muhammad Sohail Anwar, Uzma Mumtaz

Link Medical Journal · 2025

DOI: 10.61919/3drtmr18 ↗
AbstractBibliografische Angaben

Abstract

Background: Chronic kidney disease (CKD) is a progressive condition associated with substantial morbidity, polypharmacy, and altered drug pharmacokinetics, placing patients at high risk of drug-related problems (DRPs). Non-dialysis CKD (ND-CKD) patients, in particular, face increased vulnerability to adverse drug events and drug–drug interactions (DDIs), necessitating proactive pharmaceutical care. Objective: This study aimed to evaluate the prevalence, causes, and clinical outcomes of DRPs in ND-CKD patients, assess the nature and acceptance of pharmacist-led interventions, and identify associations between Pharmaceutical Care Network Europe (PCNE) domains and DRP outcomes. Methods: A cross-sectional study was conducted among 157 ND-CKD inpatients at Northwest General Hospital, Peshawar. DRPs were identified and classified using PCNE version 9.1, and DDIs were analyzed via Lexicomp®. Data were analyzed using descriptive statistics and multivariate logistic regression. Results: A total of 254 DRPs were identified, predominantly due to inappropriate drug selection (42.91%) and patient-related factors (26.77%). Lexicomp® detected 157 DDIs, with Category C interactions most common (68.8%). Of 278 pharmacist interventions, 80.21% were accepted, and 44.96% of DRPs were completely resolved. Significant associations were found between DRP causes, intervention acceptance, and outcomes (p

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →